Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Artigo em Inglês | MEDLINE | ID: mdl-38062773

RESUMO

In this study, a flexible deep learning system for breath analysis is created using an optimal hybrid deep learning model. To improve the quality of the gathered breath signals, the raw data are first pre-processed. Then, the most relevant features like Improved IMFCC, BFCC (bark frequency), DWT, peak detection, QT intervals, and PR intervals are extracted. Then, using these features the hybrid classifiers built into the diabetic's detection phase is trained. The diabetic detection phase is modeled with an optimized DBN and BI-GRU model. To enhance the detection accuracy of the proposed model, the weight function of DBN is fine-tuned with the newly projected Sine Customized by Marine Predators (SCMP) model that is modeled by conceptually blending the standard MPA and SCA models, respectively. The final outcome from optimized DBN and Bi-GRU is combined to acquire the ultimate detected outcome. Further, to validate the efficiency of the projected model, a comparative evaluation has been undergone. Accordingly, the accuracy of the proposed model is above 98%. The accuracy of the proposed model is 54.6%, 56.9%, 56.95, 44.55, 57%, 56.95, 18.2%, and 56.9% improved over the traditional models like CNN + LSTM, CNN + LSTM, CNN, LSTM, RNN, SVM, RF, and DBN, at 60th learning percentage.


Assuntos
Líquidos Corporais , Aprendizado Profundo , Diabetes Mellitus , Humanos , Diabetes Mellitus/diagnóstico , Expiração
2.
J Cosmet Dermatol ; 22(9): 2471-2475, 2023 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-37365973

RESUMO

BACKGROUND: Squamous cell carcinoma (SCC) is the second most common cutaneous malignancy, after basal cell carcinoma (BCC). Photodynamic therapy (PDT) involves converting a photosensitizer to reactive oxygen intermediates, which preferentially bind to hyperproliferative tissue. The most commonly used photosensitizers are methyl aminolevulinate and aminolevulinic acid (ALA). Presently, ALA-PDT is approved in the US and Canada for the treatment of actinic keratoses on the face, scalp, and upper extremities. AIMS: This cohort study evaluated the safety, tolerability, and efficacy of aminolevulinic acid, pulsed dye laser, and photodynamic therapy (ALA-PDL-PDT) for treatment of facial cutaneous squamous cell carcinoma in situ (isSCC). METHODS: Twenty adult patients with biopsy-confirmed isSCC on the face were recruited. Only lesions 0.4-1.3 cm in diameter were included. Patients underwent two treatments with ALA-PDL-PDT spaced 30 days apart. The isSCC lesion was then excised 4-6 weeks following the second treatment for histopathological assessment. RESULTS: No residual isSCC was detected in 17/20 (85%) patients. Two of the patients with residual isSCC had skip lesions present that explained the treatment failure. Excluding the patients with skip lesions, the posttreatment histological clearance rate was 17/18 (94%). Minimal side effects were reported. LIMITATIONS: Our study was limited by small sample size and lack of long-term recurrence data. CONCLUSIONS: The ALA-PDL-PDT protocol is a safe and well-tolerated treatment option for isSCC on the face, providing excellent cosmetic and functional results.


Assuntos
Carcinoma de Células Escamosas , Lasers de Corante , Fotoquimioterapia , Neoplasias Cutâneas , Adulto , Humanos , Ácido Aminolevulínico , Fotoquimioterapia/efeitos adversos , Fotoquimioterapia/métodos , Carcinoma de Células Escamosas/terapia , Estudos de Coortes , Lasers de Corante/efeitos adversos , Neoplasias Cutâneas/etiologia , Fármacos Fotossensibilizantes , Resultado do Tratamento
3.
Altern Ther Health Med ; 29(4): 246-252, 2023 May.
Artigo em Inglês | MEDLINE | ID: mdl-34264859

RESUMO

Trace elements (microminerals) play a role in many physiological functions, including hormone production and cellular growth. However, their importance in diagnosing and treating dermatologic disease has not been well examined. In this review, we discuss the functions, sources, and recommended requirements of each micromineral. In addition, we analyze the systemic and dermatological manifestations associated with micromineral imbalances. The pathogenesis of genodermatoses, such as Wilson disease, Menkes disease, acrodermatitis enteropathica, and allergic dermatitis, are also discussed. Included are studies examining the potential therapeutic role of zinc, selenium, and copper in inflammatory diseases, skin cancer, and photoaging.


Assuntos
Acrodermatite , Dermatologia , Oligoelementos , Humanos , Oligoelementos/uso terapêutico , Zinco/uso terapêutico , Cobre , Acrodermatite/diagnóstico , Acrodermatite/tratamento farmacológico
5.
J Cosmet Dermatol ; 20(12): 3759-3781, 2021 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-34741573

RESUMO

BACKGROUND: Androgenetic alopecia (AGA) is the most common form of hair loss consisting of a characteristic receding frontal hairline in men and diffuse hair thinning in women, with frontal hairline retention, and can impact an individual's quality of life. The condition is primarily mediated by 5-alpha-reductase and dihydrotestosterone (DHT) which causes hair follicles to undergo miniaturization and shortening of successive anagen cycles. Although a variety of medical, surgical, light-based and nutraceutical treatment options are available to slow or reverse the progression of AGA, it can be challenging to select appropriate therapies for this chronic condition. AIMS: To highlight treatment options for androgenetic alopecia taking into consideration the efficacy, side effect profiles, practicality of treatment (compliance), and costs to help clinicians offer ethically appropriate treatment regimens to their patients. MATERIALS AND METHODS: A literature search was conducted using electronic databases (Medline, PubMed, Embase, CINAHL, EBSCO) and textbooks, in addition to the authors' and other practitioners' clinical experiences in treating androgenetic alopecia, and the findings are presented here. RESULTS: Although topical minoxidil, oral finasteride, and low-level light therapy are the only FDA-approved therapies to treat AGA, they are just a fraction of the treatment options available, including other oral and topical modalities, hormonal therapies, nutraceuticals, PRP and exosome treatments, and hair transplantation. DISCUSSION: Androgenetic alopecia therapy remains challenging as treatment selection involves ethical, evidence-based decision-making and consideration of each individual patient's needs, compliance, budget, extent of hair loss, and aesthetic goals, independent of potential financial benefits to the practitioners.


Assuntos
Alopecia em Áreas , Qualidade de Vida , Alopecia/tratamento farmacológico , Feminino , Finasterida/uso terapêutico , Folículo Piloso , Humanos , Masculino , Minoxidil/uso terapêutico
6.
J Drugs Dermatol ; 20(9): 964-968, 2021 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-34491021

RESUMO

Keloid and hypertrophic scars are fibroproliferative disorders resulting from abnormal wound healing in genetically susceptible individuals. Current therapies are often ineffective. Kynurenine shows promise as a topical treatment for keloids and hypertrophic scars. In this study, healthy adult male and female subjects seeking treatment for mature keloid scars were enrolled. Subjects were randomized in double-blind fashion to receive kynurenic acid 0.5% (FS2) cream (Group 1), an active onion extract comparator treatment (Group 2), or the inactive vehicle (Group 3). Each treatment was applied twice-daily. Qualitative assessments were made using the Vancouver Scar Scale (VSS), as well as the Patient and Observer Scar Assessment Scales (POSAS). Among subjects in Group 1, there was a substantial decrease in mean PGSS scores after 30 days of treatment that continued to trend downward, becoming significant versus Group 2 at days 90 and 180 (P<0.05) and versus Group 3 at day 180 (P<0.01). Based on mean VSS scores, subjects in Group 1 achieved beneficial effects that became significant versus Group 2 at day 90 (P<0.01), day 120 (P<0.05), and day 180 (P<0.001) and versus Group 3 at day 180 (P<0.05). There were no significant improvements in Groups 2 or 3. There were no adverse events or local skin reactions. The twice-daily application of FS2 Cream represents a potentially new and effective treatment for mature keloid scars. J Drugs Dermatol. 2021;20(9):964-968. doi:10.36849/JDD.6197.


Assuntos
Cicatriz Hipertrófica , Queloide , Administração Tópica , Adulto , Cicatriz Hipertrófica/tratamento farmacológico , Método Duplo-Cego , Feminino , Humanos , Queloide/tratamento farmacológico , Queloide/patologia , Masculino , Pele/patologia , Resultado do Tratamento
7.
J Cosmet Dermatol ; 20(10): 3133-3146, 2021 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-34378298

RESUMO

BACKGROUND: Botulinum toxin A (BoNT-A) has grown tremendously in aesthetic dermatology since 2002 when the United States Food and Drug Administration (FDA) first approved its use for treating moderate-to-severe glabellar lines. Blepharoptosis, due to local spread of toxin, is a reported side effect of BoNT-A which, although rare, more frequently occurs among inexperienced practitioners. OBJECTIVES: The purpose of this review is to highlight the causes and management of eyelid ptosis secondary to BoNT-A administration including new anatomic pathways for BoNT-A spread from the brow area to the levator palpebrae superioris muscle. METHODS: A literature search was conducted using electronic databases (PubMed, Science Direct, MEDLINE, Embase, CINAHL, EBSCO) regarding eyelid anatomy and the underlying pathogenesis, presentation, prevention, and treatment of eyelid ptosis secondary to BoNT-A. Anatomic dissection has been performed to assess the role of neurovascular pedicles and supraorbital foramen anatomic variations. RESULTS: Blepharoptosis occurs due to weakness of the levator palpebrae superioris muscle. Mean onset is 3-14 days after injection and eventually self-resolves after the paralytic effect of BoNT-A wanes. Administration of medications, such as oxymetazoline hydrochloride or apraclonidine hydrochloride eye drops, anticholinesterase agents, or transdermal BoNT-A injections to the pre-tarsal orbicularis, can at least partially reverse eyelid ptosis. Anatomic study shows that a supraorbital foramen may be present in some patients and constitutes a shortcut from the brow area directly into the orbital roof, following the supraorbital neurovascular pedicle. CONCLUSION: Providers should understand the anatomy and be aware of the causes and treatment for blepharoptosis when injecting BoNT-A for the reduction of facial wrinkles. Thorough anatomic knowledge of the supraorbital area and orbital roof is paramount to preventing incorrect injection into "danger zones," which increase the risk of eyelid ptosis.


Assuntos
Blefaroptose , Toxinas Botulínicas Tipo A , Fármacos Neuromusculares , Envelhecimento da Pele , Blefaroptose/induzido quimicamente , Toxinas Botulínicas Tipo A/efeitos adversos , Humanos , Fármacos Neuromusculares/efeitos adversos , Músculos Oculomotores
8.
Cutis ; 107(3): E29-E36, 2021 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-33956620

RESUMO

Metastatic breast cancer initially may present with cutaneous lesions. The goal of this systematic review was to evaluate available reports where the initial discovery of primary breast cancer occurred through the diagnosis of metastatic cutaneous lesions. We aimed to better understand these cases and the role of dermatologists in their diagnosis. A review of the literature for case reports and retrospective studies was conducted using the following databases: MEDLINE/PubMed, EMBASE, Cochrane library, CINAHL, and EBSCO. The PRISMA guidelines were utilized. Studies were included if they reported a cutaneous metastasis of a primary breast cancer in females. Studies were excluded if skin metastasis occurred in a patient with a history of breast cancer. Thirty-six publications were identified. Among these, 27 were case reports, and 9 were retrospective reviews. An enhanced understanding of how these cutaneous metastases present may be of clinical benefit to physicians, particularly dermatologists.


Assuntos
Neoplasias da Mama , Neoplasias Cutâneas , Neoplasias da Mama/diagnóstico , Feminino , Humanos , Estudos Retrospectivos , Neoplasias Cutâneas/diagnóstico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...